S. 3014 · 119th Congress · Health

Ensuring Timely Access to Generics Act of 2025

In committee1.1k words Introduced Oct 16, 2025 · Latest action Oct 16, 2025

How far it has goneStage 2 of 6
  1. IntroducedOct 16, 2025 Done
  2. CommitteeReferred to Health, Education, Labor, and Pensions Current stage
  3. Senate floorNot yet Not reached yet
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

10 organizations · 26 filings · Q4 2025–Q3 2026

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Blue Cross Blue Shield of Michigan 3 of 4 quarters
    “Issues: Generics access; Prescription Drug Cost; PBM Reform and Prescription Drug Policy Bills: S.3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1096 - Preserve Access to Affordable…”

    Q3 2026 filing · $829K lobbying spend in 2026 to date, all issues

  2. Bluecross Blueshield of Tennessee 3 of 4 quarters
    “Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen…”

    Q3 2026 filing · $780K lobbying spend in 2026 to date, all issues

  3. Blue Cross and Blue Shield of Kansas Inc 3 of 4 quarters
    “Generics access; Prescription Drug Cost; PBM Reform and Prescription Drug Policy S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S.3014 - Ensuring Timely Access to…”

    Q3 2026 filing · $30K lobbying spend in 2026 to date, all issues

7 more organizations, every filingPROUpgrade

Organizations that named S. 3014 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Oct 16, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Oct 16, 2025Introduced in Senate